Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Could scorpion venom inspire new treatments for liver disease?

Could scorpion venom inspire new treatments for liver disease?

JMIR Publications: Emerging health tech trends

JMIR Publications: Emerging health tech trends

Giving immunotherapy before surgery boosts brain tumor treatment success

Giving immunotherapy before surgery boosts brain tumor treatment success

Virginia Tech virologist wins federal award to study cellular virus battles

Virginia Tech virologist wins federal award to study cellular virus battles

Skull bone marrow contains immune hubs that fight brain cancer

Skull bone marrow contains immune hubs that fight brain cancer

Laser treatment may extend survival in glioblastoma patients

Laser treatment may extend survival in glioblastoma patients

New microfluidic chip predicts personalized glioblastoma treatment responses

New microfluidic chip predicts personalized glioblastoma treatment responses

Cannabis compounds may weaken glioblastoma response to chemotherapy and radiation

Cannabis compounds may weaken glioblastoma response to chemotherapy and radiation

Genetic tool turns soft cancer cells into immune targets

Genetic tool turns soft cancer cells into immune targets

HonorHealth begins trial of dendritic cell vaccine for advanced melanoma

HonorHealth begins trial of dendritic cell vaccine for advanced melanoma

Immune cell interaction timing impacts glioblastoma treatment response

Immune cell interaction timing impacts glioblastoma treatment response

Scientists combine imaging and phototherapy in a single tool against glioblastoma

Scientists combine imaging and phototherapy in a single tool against glioblastoma

Patient-derived tumor models strengthen precision oncology research

Patient-derived tumor models strengthen precision oncology research

Expanded DepMap reveals new cancer vulnerabilities through 3D tumor models

Expanded DepMap reveals new cancer vulnerabilities through 3D tumor models

New ultrasound technique breaches blood brain barrier to treat gliomas

New ultrasound technique breaches blood brain barrier to treat gliomas

Researchers find potential pathway to improve glioblastoma treatment

Researchers find potential pathway to improve glioblastoma treatment

Brain cancer Achilles heel revealed in the hours after surgery

Brain cancer Achilles heel revealed in the hours after surgery

New human tissue model tracks aggressive brain tumor infiltration

New human tissue model tracks aggressive brain tumor infiltration

Spermidine boosts key cellular processes linked to aging in early research

Spermidine boosts key cellular processes linked to aging in early research

UVA researchers develop a new experimental approach to target glioblastoma

UVA researchers develop a new experimental approach to target glioblastoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.